AI assistant
Sending…
Hoth Therapeutics, Inc. — Director's Dealing 2021
Feb 16, 2021
34935_dirs_2021-02-16_f30b0461-0897-4440-9bdc-a65b7e1afbd1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: Hoth Therapeutics, Inc. (HOTH)
CIK: 0001711786
Period of Report: 2020-05-26
Reporting Person: Hayes Anthony (Former Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-05-26 | Common Stock, par value $0.0001 | S | 0 | — | Disposed | 0 | Direct |
More from Hoth Therapeutics, Inc.
Board/Management Information
2026
Jun 3
Capital/Financing Update
2026
Jun 3
Capital/Financing Update
2026
Jun 3
Regulatory Filings
2026
Jun 2
Capital/Financing Update
2026
May 28
Share Issue/Capital Change
2026
May 27
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 21
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 6